2020
DOI: 10.1080/09537104.2020.1784403
|View full text |Cite
|
Sign up to set email alerts
|

Diagnostic challenges in von Willebrand disease. Report of two cases with emphasis on multimeric and molecular analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 12 publications
0
1
0
Order By: Relevance
“…Visualization of VWF multimers was achieved using a commercially available enhanced chemiluminescence kit for detecting horseradish peroxidaselabeled antibodies on Western blots. 29 In addition, VWF-cleaving protease (ADAMTS13) activity was assessed by fluorescence resonance energy transfer (Fluoroskan Ascent FL, Thermo Fisher Scientific, Waltham, MA). Plasminogen activator inhibitor antigen (PAI) and thrombomodulin (TM) were measured by ELISA (Imubind, BioMedica Diagnostics, Windsor, Canada and Biomatik Corporation, respectively).…”
Section: Assessment Of Circulating Biomarkersmentioning
confidence: 99%
“…Visualization of VWF multimers was achieved using a commercially available enhanced chemiluminescence kit for detecting horseradish peroxidaselabeled antibodies on Western blots. 29 In addition, VWF-cleaving protease (ADAMTS13) activity was assessed by fluorescence resonance energy transfer (Fluoroskan Ascent FL, Thermo Fisher Scientific, Waltham, MA). Plasminogen activator inhibitor antigen (PAI) and thrombomodulin (TM) were measured by ELISA (Imubind, BioMedica Diagnostics, Windsor, Canada and Biomatik Corporation, respectively).…”
Section: Assessment Of Circulating Biomarkersmentioning
confidence: 99%